CD7-Positive Hematological Malignancies: Clinical Trials

1 trial for CD7-Positive Hematological Malignancies, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting. 1 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable1Not yet recruiting 1

Follow CD7-Positive Hematological Malignancies: new trials by email Literature Review of CD7-Positive Hematological Malignancies trials Research Report on CD7-Positive Hematological Malignancies

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Clinical Study on the Safety and Efficacy of CD7-Targeted Chimeric Antigen Receptor (CAR) Gene-Modified T Cells for the Treatment of CD7-Positive Hematological Malignancies
CD7-Targeted Chimeric Antigen Receptor (CAR) Gene-Modified T Cells for the Treatment of CD7-Positive Hematological Malignancies - CD7-Positive Hematological Malignancies
Not applicableNot yet recruitingDonghua Zhang282026-12-312026-01-16

Interventions

Automobiles (1)

Sponsors

Donghua Zhang (1)

Countries

China (1)